Neil Wintfeld

2.6k total citations
42 papers, 2.0k citations indexed

About

Neil Wintfeld is a scholar working on Infectious Diseases, Epidemiology and Oncology. According to data from OpenAlex, Neil Wintfeld has authored 42 papers receiving a total of 2.0k indexed citations (citations by other indexed papers that have themselves been cited), including 9 papers in Infectious Diseases, 9 papers in Epidemiology and 7 papers in Oncology. Recurrent topics in Neil Wintfeld's work include HIV/AIDS Research and Interventions (7 papers), Hepatitis C virus research (7 papers) and HIV Research and Treatment (6 papers). Neil Wintfeld is often cited by papers focused on HIV/AIDS Research and Interventions (7 papers), Hepatitis C virus research (7 papers) and HIV Research and Treatment (6 papers). Neil Wintfeld collaborates with scholars based in United States, Germany and Italy. Neil Wintfeld's co-authors include Jesse Green, Mette Hammer, John Cawley, Timothy M. Dall, April P. Semilla, Michael L. Ganz, Bo Pang, Wenya Yang, J Langer and Qian Li and has published in prestigious journals such as New England Journal of Medicine, Journal of Clinical Oncology and Diabetes Care.

In The Last Decade

Neil Wintfeld

42 papers receiving 1.9k citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Neil Wintfeld United States 22 470 361 336 319 306 42 2.0k
David Ansell United Kingdom 35 841 1.8× 462 1.3× 401 1.2× 558 1.7× 321 1.0× 121 3.7k
Raoh‐Fang Pwu Taiwan 20 743 1.6× 317 0.9× 197 0.6× 590 1.8× 318 1.0× 46 2.6k
Hong Gwan Seo South Korea 25 312 0.7× 341 0.9× 237 0.7× 89 0.3× 75 0.2× 80 3.0k
Kui Son Choi South Korea 37 928 2.0× 506 1.4× 394 1.2× 217 0.7× 121 0.4× 210 5.0k
Usa Chaikledkaew Thailand 25 390 0.8× 154 0.4× 124 0.4× 255 0.8× 72 0.2× 134 1.8k
Ataru Igarashi Japan 25 338 0.7× 631 1.7× 124 0.4× 669 2.1× 98 0.3× 197 2.7k
P. Ricordeau France 26 489 1.0× 235 0.7× 332 1.0× 276 0.9× 39 0.1× 69 2.4k
Thomas W. Ferguson Canada 23 253 0.5× 198 0.5× 132 0.4× 198 0.6× 175 0.6× 91 1.8k
Sameer D. Saini United States 30 763 1.6× 346 1.0× 131 0.4× 325 1.0× 340 1.1× 179 3.5k
David J. Vanness United States 25 267 0.6× 366 1.0× 102 0.3× 412 1.3× 46 0.2× 83 2.3k

Countries citing papers authored by Neil Wintfeld

Since Specialization
Citations

This map shows the geographic impact of Neil Wintfeld's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Neil Wintfeld with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Neil Wintfeld more than expected).

Fields of papers citing papers by Neil Wintfeld

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Neil Wintfeld. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Neil Wintfeld. The network helps show where Neil Wintfeld may publish in the future.

Co-authorship network of co-authors of Neil Wintfeld

This figure shows the co-authorship network connecting the top 25 collaborators of Neil Wintfeld. A scholar is included among the top collaborators of Neil Wintfeld based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Neil Wintfeld. Neil Wintfeld is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Shannon, Michael H., et al.. (2016). Pregnancy snapshot: a retrospective, observational case–control study to evaluate the potential effects of maternal diabetes treatment during pregnancy on macrosomia. Current Medical Research and Opinion. 32(7). 1183–1192. 3 indexed citations
2.
Cawley, John, Johanna Catherine Maclean, Mette Hammer, & Neil Wintfeld. (2015). Reporting error in weight and its implications for bias in economic models. Economics & Human Biology. 19. 27–44. 58 indexed citations
3.
Dall, Timothy M., Michael V. Storm, April P. Semilla, et al.. (2014). Value of Lifestyle Intervention to Prevent Diabetes and Sequelae. American Journal of Preventive Medicine. 48(3). 271–280. 38 indexed citations
4.
Ganz, Michael L., et al.. (2014). The association of body mass index with the risk of type 2 diabetes: a case–control study nested in an electronic health records system in the United States. Diabetology & Metabolic Syndrome. 6(1). 50–50. 167 indexed citations
5.
Cawley, John, Chad D. Meyerhoefer, Adam Biener, Mette Hammer, & Neil Wintfeld. (2014). Savings in Medical Expenditures Associated with Reductions in Body Mass Index Among US Adults with Obesity, by Diabetes Status. PharmacoEconomics. 33(7). 707–722. 134 indexed citations
6.
DiBonaventura, Marco, Neil Wintfeld, Jie Huang, & Amir Goren. (2013). Assessing adherence among patients with type 2 diabetes using insulin: Psychometric analysis of the morisky medication adherence scale. Value in Health. 16(3). A168–A168. 1 indexed citations
7.
8.
Διαμαντόπουλος, Α., Maurizio Benucci, Stefano Capri, et al.. (2012). Economic evaluation of tocilizumab combination in the treatment of moderate-to-severe rheumatoid arthritis in Italy. Journal of Medical Economics. 15(3). 576–585. 37 indexed citations
9.
Bergman, Gert, Marc C. Hochberg, Maarten Boers, et al.. (2010). Indirect Comparison of Tocilizumab and Other Biologic Agents in Patients with Rheumatoid Arthritis and Inadequate Response to Disease-Modifying Antirheumatic Drugs. Seminars in Arthritis and Rheumatism. 39(6). 425–441. 84 indexed citations
10.
Weide, Rudolf, et al.. (2010). Renal toxicity in patients with multiple myeloma receiving zoledronic acid vs. ibandronate: A retrospective medical records review. Journal of Cancer Research and Therapeutics. 6(1). 31–31. 30 indexed citations
11.
Marcellin, Patrick, George Lau, Stefan Zeuzem, et al.. (2008). Comparing the safety, tolerability and quality of life in patients with chronic hepatitis B vs chronic hepatitis C treated with peginterferon alpha‐2a. Liver International. 28(4). 477–485. 51 indexed citations
12.
Hornberger, John, J Michael Kilby, Neil Wintfeld, & Jesse Green. (2006). Cost-Effectiveness of Enfuvirtide in HIV Therapy for Treatment-Experienced Patients in the United States. AIDS Research and Human Retroviruses. 22(3). 240–247. 16 indexed citations
13.
Arora, Sanjeev, Christopher O’Brien, Stefan Zeuzem, et al.. (2006). Treatment of chronic hepatitis C patients with persistently normal alanine aminotransferase levels with the combination of peginterferon α‐2a (40 kDa) plus ribavirin: Impact on health‐related quality of life. Journal of Gastroenterology and Hepatology. 21(2). 406–412. 40 indexed citations
14.
Hornberger, John, Jesse Green, Neil Wintfeld, et al.. (2005). Cost-Effectiveness of Enfuvirtide for Treatment-Experienced Patients with HIV in Italy. HIV Clinical Trials. 6(2). 92–102. 10 indexed citations
15.
Cohen, Calvin, Nathan Clumeck, Jean‐Michel Molina, et al.. (2004). Health-Related Quality of Life With Enfuvirtide (ENF; T-20) in Combination With an Optimized Background Regimen. JAIDS Journal of Acquired Immune Deficiency Syndromes. 37(1). 1140–1146. 23 indexed citations
16.
17.
Hassanein, Tarek, Graham Cooksley, Mark Sulkowski, et al.. (2004). The impact of peginterferon alfa-2a plus ribavirin combination therapy on health-related quality of life in chronic hepatitis C. Journal of Hepatology. 40(4). 675–681. 89 indexed citations
18.
Cohen, Calvin, James Hellinger, Margaret M. Johnson, et al.. (2003). Patient Acceptance of Self-Injected Enfuvirtide at 8 and 24 Weeks. HIV Clinical Trials. 4(5). 347–357. 21 indexed citations
19.
Green, Jesse, et al.. (2002). Subcutaneous Injection Survey: Psychometric Evaluation of a Treatment Satisfaction Instrument Associated with a Novel HIV Medication. HIV Clinical Trials. 3(5). 387–395. 21 indexed citations
20.
Green, Jesse, Gerald M. Oppenheimer, & Neil Wintfeld. (1994). The $147,000 Misunderstanding: Repercussions of Overestimating the Cost of AIDS. Journal of Health Politics Policy and Law. 19(1). 69–90. 5 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by David Ansell Breakdown of academic impact, for papers by Raoh‐Fang Pwu Breakdown of academic impact, for papers by Hong Gwan Seo Breakdown of academic impact, for papers by Kui Son Choi Breakdown of academic impact, for papers by Usa Chaikledkaew Breakdown of academic impact, for papers by Ataru Igarashi Breakdown of academic impact, for papers by P. Ricordeau Breakdown of academic impact, for papers by Thomas W. Ferguson Breakdown of academic impact, for papers by Sameer D. Saini Breakdown of academic impact, for papers by David J. Vanness
Rankless by CCL
2026